... promising results in mouse models of colon cancer.
Likewise, the TSP's finding that more than 30 percent ... Hospital, Boston; Memorial Sloan-Kettering Cancer Center, New York; the University of Cologne ...
... limited published information regarding the breast cancer screening practices of women who were treated with chest ... M.D., of Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted ...
... method to increase accuracy in detecting real cancer biomarkers that is highly reproducible across laboratories ... Lafayette, Ind., and Memorial Sloan-Kettering Cancer Center, New York City.
Proteomics ...
... a study to be presented at Europe's largest cancer congress, ECCO 15 – ESMO 34 [1], ... Melanoma/Sarcoma service at Memorial Sloan-Kettering Cancer Center (New York, USA) and who was one of the leaders of ...
... , M.D., of Memorial Sloan-Kettering Cancer Center, New York, presented the findings ... local therapy options for patients with breast cancer. The majority of women who received a surgeon recommendation ...
... School, Boston, and Memorial Sloan-Kettering Cancer Center, New York, report that tumor ... results were observed in a mouse model of prostate cancer following treatment with the same drug. As inhibition ...
Michel Sadelain and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have developed ... -regulated therapeutic gene expression in stem cell–based therapies, including cancer immunotherapy. ...
... Giancotti and Yuliya Pylayeva, at Memorial Sloan-Kettering Cancer Center, New York, has provided ... provide an effective approach for the treatment of breast cancer.
TITLE: Ras- and PI3K-dependent breast ...
... . Andrea Pusic, from Memorial Sloan-Kettering Cancer Center, New York, led a team of ... ".
Pusic and her colleagues have used their framework to develop a new patient-reported outcome measure called the ...
... co-chair Harold Varmus, president, Memorial Sloan-Kettering Cancer Center, New York City, and former director of the National Institutes of Health. "Now more than ever, the knowledge and ...
... Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, in "Issues in Long- ... appropriate treatment, aftercare and monitoring, they add.
New opioid formulas designed to minimize abuse ...
... -BMT, Marcel van den Brink and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have now identified several of the molecules required by donor-derived T cells to ...
... Brink and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have now identified ... led by Masato Kasuga, at the International Medical Center of Japan, has now determined that the protein C ...
